Oxford BioDynamics (GB:OBD) has released an update.
Oxford BioDynamics, a biotech firm focusing on precision medicine tests, is set to announce its half-year financial results on June 18, 2024. To engage with its stakeholders, the company will host a live webinar via the Yellowstone Advisory platform, wherein both current and prospective shareholders can interact with the management team.
For further insights into GB:OBD stock, check out TipRanks’ Stock Analysis page.
